Abstract
Immunoglobulin A (Iga)-isotype antibodies play an important role in immunity owing to their structure, glycosylation, localization and receptor interactions. Dysfunctions in this system can lead to multiple types of pathology. This review describes the characteristics of Iga and discusses the involvement of abnormalities in the Iga system on the development of celiac disease and Iga nephropathy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kerr MA . The structure and function of human IgA. Biochem J 1990; 271: 285–296.
Monteiro RC . Role of IgA and IgA Fc receptors in inflammation. J Clin Immunol 2011; 30: 1–9.
Solomon A . Monoclonal immunoglobulins as biomarkers of cancer. Cancer Markers 1980; 1: 57–87.
Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A . Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 2003; 18: 739–749.
Boehm MK, Woof JM, Kerr MA, Perkins SJ . The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J Mol Biol 1999; 286: 1421–1447.
Mix E, Goertsches R, Zett UK . Immunoglobulins–basic considerations. J Neurol 2006; 53 Suppl 5, V9–V17.
Woof JM, Kerr MA . The function of immunoglobulin A in immunity. J Pathol 2006; 208: 270–282.
Kutteh WH, Prince SJ, Mestecky J . Tissue origins of human polymeric and monomeric IgA. J Immunol 1982; 128: 990–995.
Mestecky J . Immunobiology of IgA. Am J Kidney Dis 1988; 12: 378–383.
Cerutti A, Rescigno M . The biology of intestinal immunoglobulin A responses. Immunity 2008; 28: 740–750.
Koch CA, Anderson D, Moran MF, Ellis C, Pawson T . SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 1991; 252: 668–674.
Mestecky J, Zikan J, Butler WT . Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains. Science 1971; 171: 1163–1165.
Brandtzaeg P, Prydz H . Direct evidence for an integrated function of J-chain and secretory component in epithelial transport of immunoglobulins. Nature 1984; 311: 71–73.
Monteiro RC, van de Winkel JG . IgA Fc receptors. Annu Rev Immunol 2003; 21: 177–204.
Tomana M, Niedermeier W, Mestecky J, Skvaril F . The differences in carbohydrate composition between the subclasses of IgA immunoglobulins. Immunochemistry 1976; 13: 325–328.
Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K et al. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Press Res 2008; 31: 29–37.
Yoo EM, Morrison SL . IgA: an immune glycoprotein. Clin Immunol 2005; 116: 3–10.
Corthesy B . Roundtrip ticket for secretory IgA: role in mucosal homeostasis? J Immunol 2007; 178: 27–32.
Fagarasan S . Evolution, development, mechanism and function of IgA in the gut. Curr Opin Immunol 2008; 20: 170–177.
Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004; 113: 1296–1306.
Wines BD, Hogarth PM . IgA receptors in health and disease. Tissue Antigens 2006; 68: 103–114.
Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P . The immune geography of IgA induction and function. Mucosal Immunol 2008; 1: 11–22.
van Epps DE, Williams RC Jr . Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med 1976; 144: 1227–1242.
van Epps DE, Reed K, Williams RC Jr . Suppression of human PMN bactericidal activity by human IgA paraproteins. Cell Immunol 1978; 36: 363–376.
Wilton JM . Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. Clin Exp Immunol 1978; 34: 423–428.
Wolf HM, Fischer MB, Puhringer H, Samstag A, Vogel E, Eibl MM . Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. Blood 1994; 83: 1278–1288.
Nikolova EB, Russell MW . Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J Leukoc Biol 1995; 57: 875–882.
Wolf HM, Hauber I, Gulle H, Samstag A, Fischer MB, Ahmad RU et al. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. Clin Exp Immunol 1996; 105: 537–543.
Olas K, Butterweck H, Teschner W, Schwarz HP, Reipert B . Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin Exp Immunol 2005; 140: 478–490.
Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, Ruffie C et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005; 22: 31–42.
Schaffer FM, Monteiro RC, Volanakis JE, Cooper MD . IgA deficiency. Immunodefic Rev 1991; 3: 15–44.
Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M et al. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor. Eur J Immunol 2007; 37: 1116–1128.
van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG . IgA and the IgA Fc receptor. Trends Immunol 2001; 22: 205–211.
Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001; 194: 417–425.
Otten MA, van Egmond M . The Fc receptor for IgA (FcalphaRI, CD89). Immunol Lett 2004; 92: 23–31.
Herr AB, Ballister ER, Bjorkman PJ . Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 2003; 423: 614–620.
Launay P, Patry C, Lehuen A, Pasquier B, Blank U, Monteiro RC . Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRgamma association and protects against degradation of bound ligand. J Biol Chem 1999; 274: 7216–7225.
Kanamaru Y, Pfirsch S, Aloulou M, Vrtovsnik F, Essig M, Loirat C et al. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation. J Immunol 2008; 180: 2669–2678.
Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H . Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993; 92: 1681–1685.
Chiamolera M, Launay P, Montenegro V, Rivero MC, Velasco IT, Monteiro RC . Enhanced expression of Fc alpha receptor I on blood phagocytes of patients with gram-negative bacteremia is associated with tyrosine phosphorylation of the FcR-gamma subunit. Shock 2001; 16: 344–348.
Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, Lebreton C, Menard S, Candalh C et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008; 205: 143–154.
Kagnoff MF . Overview and pathogenesis of celiac disease. Gastroenterology 2005; 128: S10–S18.
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801.
van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585–1588.
Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P . Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 1995; 37: 766–776.
Periolo N, Chernavsky AC . Coeliac disease. Autoimmun Rev 2006; 5: 202–208.
Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M . Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000; 119: 996–1006.
Sollid LM, Lundin KE . Diagnosis and treatment of celiac disease. Mucosal Immunol 2009; 2: 3–7.
Salmi TT, Collin P, Jarvinen O, Haimila K, Partanen J, Laurila K et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther 2006; 24: 541–552.
Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei M . Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 1996; 348: 1065–1067.
Korponay-Szabo IR, Halttunen T, Szalai Z, Laurila K, Kiraly R, Kovacs JB et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004; 53: 641–648.
Green PH, Cellier C . Celiac disease. N Engl J Med 2007; 357: 1731–1743.
Berger J, Hinglais N . Les dépôts intercapillaires d'IgA-IgG. J Urol Néphol 1968; 74: 694–695.
Galla JH . IgA nephropathy. Kidney Int 1995; 47: 377–387.
Berger J, Yaneva H, Nabarra B, Barbanel C . Reccurence of mesangial deposition of IgA after renal transplantation. Kidney Int 1975; 7: 232–241.
Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, Weening JJ, Kauffmann RH et al. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int 1984; 26: 760–766.
Novak J, Julian BA, Tomana M, Mestecky J . IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 2008; 28: 78–87.
Gonzalez-Cabrero J, Egido J, Mampaso F, Rivas MC, Hernando L . Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy. Clin Exp Immunol 1989; 76: 204–209.
van den Wall Bake AW, Bruijn JA, Accavitti MA, Crowley-Nowick PA, Schrohenloher RE, Julian BA et al. Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific. Kidney Int 1993; 44: 65–74.
Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P . Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985; 28: 666–671.
Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004; 15: 622–634.
Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N et al. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005; 16: 2667–2676.
Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504–13.
Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118: 629–639.
Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077–1085.
Kokubo T, Hiki Y, Iwase H, Horii A, Tanaka A, Nishikido J et al. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1–IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 1997; 8: 915–919.
Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J . Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104: 73–81.
Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119: 1668–1677.
Almogren A, Kerr MA . Irreversible aggregation of the Fc fragment derived from polymeric but not monomeric serum IgA1—implications in IgA-mediated disease. Mol Immunol 2008; 45: 87–94.
Launay P, Grossetete B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191: 1999–2009.
Monteiro RC, Moura IC, Launay P, Tsuge T, Haddad E, Benhamou M et al. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 2002; 8: 464.
van den Wall Bake AW, Kirk KA, Gay RE, Switalski LM, Julian BA, Jackson S et al. Binding of serum immunoglobulins to collagens in IgA nephropathy and HIV infection. Kidney Int 1992; 42: 374–382.
Cederholm B, Wieslander J, Bygren P, Heinegard D . Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 1988; 85: 4865–4868.
Shinkai Y, Karai M, Osawa G, Sato M, Koshikawa S . Antimouse laminin antibodies in IgA nephropathy and various glomerular diseases. Nephron 1990; 56: 285–296.
Zheng F, Kundu GC, Zhang Z, Ward J, DeMayo F, Mukherjee AB . Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice. Nature Med 1999; 5: 1018–1025.
Coppo R, Chiesa M, Cirina P, Peruzzi L, Amore A . In human IgA nephropathy uteroglobin does not play the role inferred from transgenic mice. Am J Kidney Dis 2002; 40: 495–503.
Collin P, Syrjanen J, Partanen J, Pasternack A, Kaukinen K, Mustonen J . Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol 2002; 97: 2572–2576.
Jhaveri KD, D'Agati VD, Pursell R, Serur D . Coeliac sprue-associated membranoproliferative glomerulonephritis (MPGN). Nephrol Dial Transplant 2009; 24: 3545–3548.
Biyikli NK, Gokce I, Cakalagoglu F, Arbak S, Alpay H . The co-existence of membranoproliferative glomerulonephritis type 1 and coeliac disease: a case report. Pediatr Nephrol 2009; 24: 1247–1250.
Prasad D, Khara HS, Gupta M, Sterman P . Celiac disease associated membranous nephropathy—a rare cause or coincidence? A case report. Cases J 2009; 2: 7018.
Pasternack A, Collin P, Mustonen J, Reunala T, Rantala I, Laurila K et al. Glomerular IgA deposits in patients with celiac disease. Clin Nephrol 1990; 34: 56–60.
Coppo R, Amore A, Roccatello D . Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 1992; 2: S173–S180.
Fornasieri A, Sinico RA, Maldifassi P, Bernasconi P, Vegni M, D'Amico G . IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). Br Med J 1987; 295: 78–80.
Pierucci A, Fofi C, Bartoli B, Simonetti BM, Pecci G, Sabbatella L et al. Antiendomysial antibodies in Berger's disease. Am J Kidney Dis 2002; 39: 1176–1182.
La Villa G, Pantaleo P, Tarquini R, Cirami L, Perfetto F, Mancuso F et al. Multiple immune disorders in unrecognized celiac disease: a case report. World J Gastroenterol 2003; 9: 1377–1380.
Coppo R, Roccatello D, Amore A, Quattrocchio G, Molino A, Gianoglio B et al. Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol 1990; 33: 72–86.
Kovacs T, Kun L, Schmelczer M, Wagner L, Davin JC, Nagy J . Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Am J Nephrol 1996; 16: 500–505.
Rostoker G, Delchier JC, Chaumette MT . Increased intestinal intra-epithelial T lymphocytes in primary glomerulonephritis: a role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides? Nephrol Dial Transplant 2001; 16: 513–517.
Smerud HK, Fellstrom B, Hallgren R, Osagie S, Venge P, Kristjansson G . Gluten sensitivity in patients with IgA nephropathy. Nephrol Dial Transplant 2009; 24: 2476–2481.
Amore A, Emancipator SN, Roccatello D, Gianoglio B, Peruzzi L, Porcellini MG, et al. Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. Am J Kidney Dis 1994; 23: 290–301.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papista, C., Berthelot, L. & Monteiro, R. Dysfunctions of the Iga system: a common link between intestinal and renal diseases. Cell Mol Immunol 8, 126–134 (2011). https://doi.org/10.1038/cmi.2010.69
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2010.69
Keywords
This article is cited by
-
Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection
Protein & Cell (2021)
-
IgA glycosylation and immune complex formation in IgAN
Seminars in Immunopathology (2021)
-
Role of IgA receptors in the pathogenesis of IgA nephropathy
Journal of Nephrology (2016)
-
Gluten exacerbates IgA nephropathy in humanized mice through gliadin–CD89 interaction
Kidney International (2015)
-
A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy
BMC Medical Informatics and Decision Making (2012)